Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-01 Sale | 2026-06-01 7:11 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 4,653 | $23.77 | $110,602 | 105,689 (Direct) | View |
| 2026-05-01 Sale | 2026-05-04 5:35 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 4,683 | $24.9 | $116,607 | 110,342 (Direct) | View |
| 2026-04-01 Sale | 2026-04-02 6:19 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 4,683 | $20.97 | $98,203 | 80,351 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 6:50 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 10,044 | $22.65 | $227,538 | 85,034 (Direct) | View |
| 2026-02-02 Sale | 2026-02-03 12:00 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 3,061 | $23.56 | $72,117 | 88,935 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 4:07 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 3,150 | $22.84 | $71,946 | 91,996 (Direct) | View |
| 2025-12-10 Sale | 2025-12-11 12:10 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 3,081 | $36.38 | $112,087 | 95,146 (Direct) | View |
| 2025-10-13 Sale | 2025-10-14 12:15 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 7,942 | $31.51 | $250,252 | 98,227 (Direct) | View |
| 2025-03-06 Sale | 2025-03-10 12:53 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 1,785 | $40.4 | $72,114 | 106,169 (Direct) | View |
| 2024-10-10 Sale | 2024-10-11 4:48 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 7,465 | $52.76 | $393,853 | 92,301 (Direct) | View |
| 2023-02-23 Sale | 2023-02-24 8:36 pm | Vir Biotechnology Inc. | VIR | Horn Howard CFO | 2,248 | $25.97 | $58,387 | 230,712 (Direct) | View |
| 2023-02-17 Sale | 2023-02-21 7:22 pm | Vir Biotechnology Inc. | VIR | Horn Howard CFO | 2,424 | $25.29 | $61,298 | 232,960 (Direct) | View |
| 2022-02-17 Sale | 2022-02-22 5:00 pm | Vir Biotechnology Inc. | VIR | Horn Howard CFO | 2,393 | $31.93 | $76,411 | 200,384 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-16 Option Award | 2026-04-20 5:09 pm | N/A 2036-04-16 | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 94,626 | $0 | 174,977 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:50 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 6,143 | $0 | 85,034 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 7:56 pm | N/A 2035-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 43,813 | $0 | 136,114 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:23 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 53,600 | $0 | 133,966 (Direct) | View |
| 2023-10-09 Option Award | 2023-10-10 12:50 pm | N/A 2033-10-09 | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 220,835 | $0 | 220,805 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:29 pm | N/A 2032-02-21 | Vir Biotechnology Inc. | VIR | Horn Howard CFO | 85,000 | $0 | 285,384 (Direct) | View |